<DOC>
	<DOCNO>NCT01890967</DOCNO>
	<brief_summary>This study design define amount duration cholesterol lower assess safety tolerability different dose regimen LY3015014 participant high cholesterol . The study also investigate body process drug drug affect body . Participants remain stable diet continue take cholesterol-lowering medication ( statin without ezetimibe ) . After sign informed consent document , participant complete screening/run-in period last 8 week . Then , treatment period last approximately 16 week . After treatment period , participant complete follow-up period last approximately 8 week total study duration range approximately 25 32 week .</brief_summary>
	<brief_title>A Study LY3015014 Participants With High Cholesterol</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>Diagnosed high low density lipoprotein ( LDL ) cholesterol Are stable daily dose statin history statin intolerance Men partner become pregnant must agree use barrier protection sexual intercourse prevent pregnancy Women become pregnant , woman pregnant breast feeding agree use reliable method birth control prevent pregnancy Have high cholesterol due another disease rare serious form hereditary high cholesterol Have recent heart attack , stroke , blood clot heart surgery , plan heart blood vessel surgery , heart pump sufficiently well Have poorly control high blood pressure Have diabetes require injectable medication ( include insulin ) , diabetes poorly control Have thyroid blood test outside normal range Have history adrenal gland disorder Have history vitamin E deficiency fat malabsorption syndrome Have poor kidney function Have active liver gall bladder disease , history hepatitis liver blood test high Have history muscle disease include muscle damage medicine muscle blood test high Are anemic ( low red blood cell count ) Have history allergy intolerance antibody medication Have history human immunodeficiency virus infection ( HIV ) infection Are likely major operation hospitalize study Have chronic alcohol drug abuse dependency Have suspect cancer malignant tumor Have active serious infection Have start stop take statin ezetimibe medication , change statin dose regimen recently Are statin regimen daily dose ( example , everyotherday statin regimen ) Have recently use simvastatin ( high dose level ) , fibrates , bile acid binder , niacin , probucol , overthecounter/health food preparation low cholesterol ( red yeast rice , fish oil , omega 3 fatty acid ) Have undergone LDL apheresis past 1 year Have recently use steroid , cyclosporine isotretinoin Have recently use immunosuppressive therapy Have recently receive treatment another antibody medication Are currently use medication inject skin , except single injection ( example flu vaccine ) injection muscle Are currently prescription overthecounter medicine weight loss low carbohydrate diet</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>low density lipoprotein , heterozygous familial hypercholesterolemia , polygenic hypercholesterolemia</keyword>
</DOC>